David MacManus

BREAKDOWN OF THE BLOOD-BRAIN BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE SCLEROSIS

Allan G. Kermode, Alan J. Thompson, Paul S. Tofts et al. · Brain · 1990 · 581 citations

Medicine, Neurology, Neuroscience +17

Head size, age and gender adjustment in MRI studies: a necessary nuisance?

Josephine Barnes, Gerard R. Ridgway, Jonathan W. Bartlett et al. · NeuroImage · 2010 · 528 citations

Medicine, Radiology, Biomedical Imaging +7

Major differences in the dynamics of primary and secondary progressive multiple sclerosis

Alan J. Thompson, Allan G. Kermode, David Wicks et al. · Annals of Neurology · 1991 · 491 citations

Medicine, Neurology, Diagnostic Imaging +12

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Ludwig Kappos, Ralf Gold, David H. Miller et al. · The Lancet · 2008 · 479 citations · Full text

Medicine, Neurology, Pharmacotherapy +6

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

Jeremy Chataway, Nadine Schuerer, Ali Alsanousi et al. · The Lancet · 2014 · 448 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15